Abstract：With the increasing incidence of myopia in children and a younger age of myopia onset, myopia has become a global public health problem, which needs to be addressed immediately. Effective interventions for myopia control include bifocal glasses, multi-focal glasses, orthokeratology lens and pharmacologic, etc. Recently, atropine eye drops have obtained widespread concern for its effectiveness in suppressing the myopia progression. As low-dose atropine can effectively control myopia progression and axial growth, with significantly less adverse events such as photophobia and blurred near vision compared to higher concentration preparation, low-concentration atropine has become one of the important research areas for myopia prevention and control in children. This article summarizes the research progress of lowconcentration atropine in myopia control of children.
杨璐绫, 吕会斌, 陈跃国, 等. 低浓度阿托品在儿童近视控制中的研究进展[J]. 中华眼视光学与视觉科学杂志, 2022, 24(12): 956-960.
Luling yang, Huibin Lyu, Yueguo Chen,et al. Research Progress of Low-Concentration Atropine for Myopia Control in Children. Chinese Journal of Optometry Ophthalmology and Visual science, 2022, 24(12): 956-960. DOI: 10.3760/cma.j.cn115909-20201207-00471
浙公网安备 33030202001892号